Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$1.92 - $6.28 $14,279 - $46,704
-7,437 Closed
0 $0
Q1 2021

May 03, 2021

SELL
$14.52 - $23.53 $9,408 - $15,247
-648 Reduced 8.01%
7,437 $132,000
Q2 2020

Jul 28, 2020

BUY
$12.21 - $16.99 $46,923 - $65,292
3,843 Added 90.59%
8,085 $119,000
Q1 2020

May 06, 2020

BUY
$9.03 - $19.72 $13,210 - $28,850
1,463 Added 52.64%
4,242 $57,000
Q4 2017

Jan 31, 2018

BUY
$13.26 - $22.86 $14,758 - $25,443
1,113 Added 66.81%
2,779 $54,000
Q3 2017

Nov 08, 2017

BUY
$19.76 - $24.9 $32,920 - $41,483
1,666
1,666 $36,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $555M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.